FXPLM Markets Ltd has taken a significant step by filing a new Form D with the SEC, aiming to raise up to $100 million. This move reflects the company's strategy to enhance its capital base and expand its investment activities.
The filing, dated October 30, 2026, is particularly important as it indicates the company's commitment to growth in the competitive investing industry. FXPLM Markets Ltd, which was formerly known as Anz Global Ltd, is based in Louisville, Kentucky, and has been operational for over five years.
Company Overview
FXPLM Markets Ltd is an investment company incorporated in Kentucky. The company operates under the Central Index Key (CIK) number 0002129316. The firm focuses on various investment strategies, which are detailed in its recent filings. As of the latest update, FXPLM is positioned to leverage its new funding to explore more investment opportunities.
What the Filing Says
The SEC filing outlines that FXPLM Markets Ltd is seeking to raise an indefinite amount of capital, with a total offering amount of $100 million. The filing indicates that the company has already secured investments totaling $10,000,000.
"The total amount sold is $100,000,000, with the total remaining being indefinite," the filing states.
Impact
This fundraising initiative may affect various stakeholders, including potential investors and the broader investment community. FXPLM Markets Ltd's move to attract significant capital could enhance its competitive edge in the investing sector, which is characterized by a growing demand for innovative investment solutions.
What's Next
The filing does not specify what happens next regarding the fundraising efforts or any subsequent actions the company may take.
For further details, the filing can be accessed via the SEC's EDGAR database under accession number 0002129316-26-000003.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










